Pharmacist Prescribing Models for HIV Pre-exposure and Post-exposure Prophylaxis. 2023

Alex J Adams, and Michael E Klepser
Division of Financial Management, Idaho, Boise, ID, USA.

State strategies for pharmacist prescribing exist on a continuum from most restrictive to least restrictive. Using human immunodeficiency virus (HIV) pre-exposure prophylaxis and post-exposure prophylaxis as a case study, there are 3 viable pharmacist prescribing models: (1) population-based collaborative practice agreements; (2) government protocols; and (3) standard of care prescribing. The advantages and disadvantages of these 3 models are reviewed.

UI MeSH Term Description Entries

Related Publications

Alex J Adams, and Michael E Klepser
December 2020, Australian prescriber,
Alex J Adams, and Michael E Klepser
April 2018, Journal of acquired immune deficiency syndromes (1999),
Alex J Adams, and Michael E Klepser
January 2013, American journal of preventive medicine,
Alex J Adams, and Michael E Klepser
January 2023, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC,
Alex J Adams, and Michael E Klepser
November 2021, American journal of preventive medicine,
Alex J Adams, and Michael E Klepser
October 2021, AIDS patient care and STDs,
Alex J Adams, and Michael E Klepser
January 2020, Journal of the American Pharmacists Association : JAPhA,
Alex J Adams, and Michael E Klepser
February 2021, The lancet. HIV,
Alex J Adams, and Michael E Klepser
December 2023, AIDS education and prevention : official publication of the International Society for AIDS Education,
Alex J Adams, and Michael E Klepser
January 1999, Advances in experimental medicine and biology,
Copied contents to your clipboard!